Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02245763 · ClinicalTrials.gov registry record
STS/ACC TVT Registry Mitral Module
A clinical trial of Mitral Valve Regurgitation, sponsored by American College of Cardiology.
- Recruiting
- Registry status
- 4,000
- Enrollment target
- 1
- Study location
NCT02245763: Recruiting study of Mitral Valve Regurgitation, sponsored by American College of Cardiology.
NCT02245763 is a study of Mitral Valve Regurgitation that is actively recruiting participants, run by American College of Cardiology. The registered enrollment target is 4,000 participants, above the 451-participant average among 11 other Mitral Valve Regurgitation trials with a reported enrollment target (787% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02245763, a study of Mitral Valve Regurgitation, is actively recruiting participants, sponsored by American College of Cardiology.
- RECRUITING
- Registry status
- 4,000 participants
- Enrollment target
- 1
- Study location
Study Summary
The TVT Registry™ is a benchmarking tool developed to track patient safety and real-world outcomes related to the transcatheter mitral valve repair (TMVR) procedure. Created by The Society of Thoracic Surgeons (STS) and the American College of Cardiology (ACC), the TVT Registry is designed to monitor the safety and efficacy of this new procedure for the treatment of mitral valve disease.
Conditions Studied
Interventions
- DEVICE Leaflet Clip
Study Locations (1)
District of Columbia
- American College of Cardiology - Washington D.C.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 4,000 participants |
| Start Date | 2013-11 |
| Est. Completion | 2030-12-31 |
What NCT02245763 shows while recruiting
NCT02245763 is an observational study that tracks outcomes without assigning an intervention. Its 4,000 participants enrollment target places it among the larger protocols in the corpus, above the 451-participant average among 11 other Mitral Valve Regurgitation trials with a reported enrollment target (787% higher).
The record links to 1 condition, with Mitral Valve Regurgitation appearing as the primary indexed condition, and to 1 intervention - of which Leaflet Clip is the first listed.
NCT02245763 reports a single indexed study location in District of Columbia.
Frequently Asked Questions
What is clinical trial NCT02245763 about?
NCT02245763 is a clinical study titled "STS/ACC TVT Registry Mitral Module". The TVT Registry™ is a benchmarking tool developed to track patient safety and real-world outcomes related to the transcatheter mitral valve repair (TMVR) procedure. Created by The Society of Thoracic Surgeons (STS) and the American College of Cardiology (ACC), the TVT Registry is designed to monito...
What is the current status of trial NCT02245763?
This trial is currently recruiting. The enrollment target is 4,000 participants. The study started on 2013-11. Estimated completion is 2030-12-31.
What conditions does trial NCT02245763 study?
This clinical trial studies the following conditions: Mitral Valve Regurgitation.
What interventions are being tested in trial NCT02245763?
The interventions under investigation include: Leaflet Clip (DEVICE).
Who is sponsoring clinical trial NCT02245763?
This trial is sponsored by American College of Cardiology, which has 3 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02245763 being conducted?
This trial has 1 study location across District of Columbia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Mitral Valve Regurgitation
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02245763's enrollment target sits among peer trials
4,000 1st of 11 higher than 11 of 11 other Mitral Valve Regurgitation trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Mitral Valve Regurgitation trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Percutaneous or Surgical Repair In Mitral Prolapse And Regurgitation for ≥60 Year-olds (PRIMARY)
RECRUITING · NA
-
AltaValve Pivotal Trial
RECRUITING · NA
-
Transcatheter Mitral Valve Replacement With the Medtronic Intrepid™ TMVR System in Patients With Severe Symptomatic Mitral Regurgitation.
RECRUITING · NA
-
Early Feasibility Study of the Neovasc Tiara™ Mitral Valve System
ACTIVE NOT RECRUITING · NA
-
PARTNER 3 Trial - Mitral Valve in Valve
ACTIVE NOT RECRUITING · NA
-
MitraClip REPAIR MR Study
ACTIVE NOT RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00227253 · 4,000 participants
Chromosome 18 Clinical Research Center
- NCT00811148 · 4,000 participants
Florida Center for Brain Tumor Research
- NCT00897117 · 4,000 participants
Collecting and Analyzing Tissue Samples From Patients Undergoing Surgery for Non-Small Cell Lung Cancer
- NCT00899301 · 4,000 participants
Collecting and Storing Tissue Samples From Women With or Without Breast Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia